Literature DB >> 12591204

Comparative safety and efficacy of attenuated single-strain and multi-strain vaccines for porcine reproductive and respiratory syndrome.

William L Mengeling1, Kelly M Lager, Ann C Vorwald, Deborah F Clouser.   

Abstract

The objective of this study was to compare the efficacy and safety of single-strain and multi-strain vaccines for the prevention of the respiratory facet of porcine reproductive and respiratory syndrome. The study comprised six groups of pigs (A through F, eight pigs per group). At the beginning of the study (Day 0) Groups C and D were vaccinated with a single-strain vaccine, and Groups E and F were vaccinated with a multi-strain vaccine. The multi-strain vaccine contained five attenuated strains of PRRSV including the strain used as the single-strain vaccine. On Day 28 Groups B (nonvaccinated/challenged control), D, and F were challenged with a highly virulent field strain of PRRSV that was unrelated to any of the strains used for vaccination. Group A was kept as a nonvaccinated/nonchallenged control. On Day 42 all pigs were necropsied. Their lungs and lymph nodes were examined for virus-induced changes. Serum samples obtained at weekly intervals during the study and lung lavage fluids obtained at necropsy were tested for the presence and titer of PRRSV. Serum samples were also tested for antibody. The presence and severity of clinical signs and lesions were the primary means by which vaccine efficacy and safety were evaluated. Both vaccines provided a high level of protective immunity to challenge. However, appreciable lymph node enlargement in pigs vaccinated with multi-strain vaccine, with or without subsequent challenge, raised a question as to its safety. Collectively these results indicate that both single-strain and multi-strain attenuated PRRSV vaccines can be effective immunogens, but additional studies in regard to safety are needed before multi-strain vaccines can be recommended for routine field use. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12591204     DOI: 10.1016/s0378-1135(02)00426-1

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  25 in total

1.  Suppression of porcine reproductive and respiratory syndrome virus replication in MARC-145 cells by shRNA targeting ORF1 region.

Authors:  Guanming Li; Juan Huang; Ping Jiang; Yufeng Li; Wenming Jiang; Xianwei Wang
Journal:  Virus Genes       Date:  2007-08-02       Impact factor: 2.332

Review 2.  Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects.

Authors:  Wasin Charerntantanakul
Journal:  World J Virol       Date:  2012-02-12

3.  Safety and efficacy of a novel European vaccine for porcine reproductive and respiratory virus in bred gilts.

Authors:  Michael D Piontkowski; Jeremy Kroll; Francois-Xavier Orveillon; Christian Kraft; Teresa Coll
Journal:  Can J Vet Res       Date:  2016-10       Impact factor: 1.310

4.  Reproductive parameters following a PRRS outbreak where a whole-herd PRRS MLV vaccination strategy was instituted post-outbreak.

Authors:  Em-on Olanratmanee; Suparlark Nuntawan Na Ayudhya; Roongroje Thanawongnuwech; Annop Kunavongkrit; Padet Tummaruk
Journal:  Trop Anim Health Prod       Date:  2012-12-02       Impact factor: 1.559

5.  An Attenuated Highly Pathogenic Chinese PRRS Viral Vaccine Confers Cross Protection to Pigs against Challenge with the Emerging PRRSV NADC30-Like Strain.

Authors:  Hewei Zhang; Mingqi Xia; Wei Wang; Decai Ju; Long Cao; Bai Wu; Xin Wang; Ying Wu; Ni Song; Jiaxin Hu; Changxiao Tian; Shucheng Zhang; Hua Wu
Journal:  Virol Sin       Date:  2018-03-29       Impact factor: 4.327

6.  Attenuation of porcine reproductive and respiratory syndrome virus by molecular breeding of virus envelope genes from genetically divergent strains.

Authors:  Yan-Yan Ni; Tanja Opriessnig; Lei Zhou; Dianjun Cao; Yao-Wei Huang; Patrick G Halbur; Xiang-Jin Meng
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

7.  Different biological characteristics of wild-type porcine reproductive and respiratory syndrome viruses and vaccine viruses and identification of the corresponding genetic determinants.

Authors:  Won-Il Kim; Jae-Jo Kim; Sang-Ho Cha; Kyoung-Jin Yoon
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

8.  Efficacy of Fostera PRRS modified live virus vaccine against a Canadian heterologous virulent field strain of porcine reproductive and respiratory syndrome virus.

Authors:  Christian Savard; Fernando Alvarez; Chantale Provost; Younes Chorfi; Sylvie D'Allaire; Marie-Odile Benoit-Biancamano; Carl A Gagnon
Journal:  Can J Vet Res       Date:  2016-01       Impact factor: 1.310

9.  Safety and early onset of immunity with a novel European porcine reproductive and respiratory syndrome virus vaccine in young piglets.

Authors:  Michael Piontkowski; Jeremy Kroll; Christian Kraft; Teresa Coll
Journal:  Can J Vet Res       Date:  2016-04       Impact factor: 1.310

10.  A Synthetic Porcine Reproductive and Respiratory Syndrome Virus Strain Confers Unprecedented Levels of Heterologous Protection.

Authors:  Hiep L X Vu; Fangrui Ma; William W Laegreid; Asit K Pattnaik; David Steffen; Alan R Doster; Fernando A Osorio
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.